Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze CRSP stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate CRSP investment potential.

What is CRSP stock price today?

Get real-time CRSP stock price, historical data, and price charts on Financhill. Track CRSP performance with our advanced analysis tools.

Is CRSP a good investment?

Evaluate CRSP investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy CRSP stock?

To buy CRSP stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of CRSP?

View detailed market capitalization data and company valuation metrics for CRSP on our comprehensive analysis page.

What is the P/E ratio of CRSP?

Use our fundamental analysis tools to view CRSP P/E ratio and compare valuation metrics with industry peers.

What are CRSP earnings?

View CRSP earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

CRISPR Therapeutics AG Stock Predictions

Share Price Moved. Momentum Hasn't Slowed.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Sell

CRSP
CRISPR Therapeutics AG

Last Price:

$55.22

Seasonality Move:

14.46%

7 Day Trial

ALL ACCESS PASS

$ 7

Valuation Up 5,000%. Shares Now $0.85 - Still Early?

CRISPR Therapeutics AG Stock Forecast

Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 26.2% based on the past 9 years of stock performance.
CRISPR Therapeutics AG has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
Is CRISPR Therapeutics AG Stock Undervalued?

The current CRISPR Therapeutics AG [CRSP] share price is $54.74. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will CRISPR Therapeutics AG Stock Go Up Next Year?

Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 26.2% based on the past 9 years of stock performance.

CRISPR Therapeutics AG Stock Rating

Sell

CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG overpriced?

CRISPR Therapeutics AG has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

CRISPR Therapeutics AG Stock Price History

Is CRSP stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

Switzerland

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

crisprtx.com

52-Week Data

52-Week High:

78.48

52-Week Low:

30.04

Prediction Charts

Market Cap:

5.2B

Price in USD:

54.74

Volume:

1.2M

Beta:

2.05

Technical Analysis

SMA50:

59.78

SMA100:

58.98

SMA200:

50.98

52-Wk Change:

22.65%

Stock Predictions

Is CRISPR Therapeutics AG stock public?

Yes, CRISPR Therapeutics AG is a publicly traded company.
What is the CRISPR Therapeutics AG stock quote today?

The CRISPR Therapeutics AG stock price is 54.74 USD today.
How to buy CRISPR Therapeutics AG stock online?

You can buy CRISPR Therapeutics AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-28	52.84	53.47	54.00	51.50
Dec-1	52.30	52.17	53.46	51.00
Dec-2	52.43	51.58	53.03	51.20
Dec-3	51.49	55.99	56.01	51.16
Dec-4	55.99	58.18	59.77	54.93
Dec-5	58.18	56.88	58.76	56.01
Dec-8	58.12	57.36	58.76	56.68
Dec-9	57.00	57.04	58.00	55.65
Dec-10	56.34	57.59	58.47	54.41
Dec-11	56.85	58.09	59.25	56.61
Dec-12	57.95	56.68	58.50	55.52
Dec-15	57.12	56.25	58.35	55.65
Dec-16	55.68	55.97	57.58	55.29
Dec-17	55.74	54.74	58.00	54.60

CRISPR Therapeutics AG Earnings

CRISPR Therapeutics AG Earnings Report: Per Share CRISPR Therapeutics AG Earnings Q1 Q2 Q3 and Q4 last year and next year.

CRISPR Therapeutics AG Forecast Revenue Growth

CRISPR Therapeutics AG Stock Analysis: Historical quarterly revenues per share for CRISPR Therapeutics AG and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.

* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.